Lenacapavir
CAS No. 2189684-44-2
Lenacapavir ( GS-6207 )
产品货号. M26233 CAS No. 2189684-44-2
Lenacapavir 是一种有效的 HIV 复制衣壳靶向抑制剂。 Lenacapavir 在 MT-4 细胞中显示出抗 HIV 活性,EC50 为 100 pM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥695 | 有现货 |
|
| 10MG | ¥1131 | 有现货 |
|
| 25MG | ¥2260 | 有现货 |
|
| 50MG | ¥3683 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lenacapavir
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lenacapavir 是一种有效的 HIV 复制衣壳靶向抑制剂。 Lenacapavir 在 MT-4 细胞中显示出抗 HIV 活性,EC50 为 100 pM。
-
产品描述Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.(In Vitro):Lenacapavir displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells. Lenacapavir shows sub-nanomolar potency in target cells with EC50 of 23 pM, in a full-cycle assay with EC50 of 25 pM and in producer cells with EC50 of 439 pM.
-
体外实验——
-
体内实验——
-
同义词GS-6207
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number2189684-44-2
-
分子量968.28
-
分子式C39H32ClF10N7O5S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 200 mg/mL (206.55 mM)
-
SMILES[H][C@]12C[C@@]1([H])C(F)(F)c1c2c(nn1CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)c1nc(ccc1-c1ccc(Cl)c2c(NS(C)(=O)=O)nn(CC(F)(F)F)c12)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
WRW4 TFA(878557-55-2...
Selective antagonist of formyl peptide receptor 2 (FPR2) signaling. Inhibits WKYMVm binding to FPR2 (IC50 = 0.23 μM) and inhibits intracellular calcium release induced by WKYMVm, MMK 1, amyloid β42, and F peptide. Also inhibits FPR2-mediated signaling in human neutrophils; blocks chemotactic migration and superoxide generation by amyloid β42 peptide.
-
XMP
XMP是嘌呤代谢的中间体。
-
[Sar9,Met(O2)11]-Sub...
[Sar9,Met(O2)11]-Substance P TFA is a selective tachykinin NK1 receptor agonist.[Sar9,Met(O2)11]-Substance P and septide (10-100 pmol per rat, i.c.v.) are equipotent in increasing mean arterial blood pressure (MAP) and heart rate (HR), yet they have dissimilar time-course. Both agonists increase dose-dependently face washing and sniffing while [Sar9,Met(O2)11]-Substance P is the sole to produce grooming.
021-51111890
购物车()
sales@molnova.cn

